Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weiss

Showing results (1131-1140 of 1,173) with videos related to

Pageof 118
Sort By:
The Science of the Total Environment|May 8, 2020
Comment on: "A novel approach to peatlands as archives of total cumulative spatial pollution loads from atmospheric deposition of airborne elements complementary to EMEP data: Priority pollutants (Pb, Cd, Hg)" by Ewa Miszczak, Sebastian Stefaniak, Adam Michczyński, Eiliv Steinnes and Irena TwardowskaF De Vleeschouwer, S Baron, J M Cloy, et al.
Journal of Virology|October 4, 2024
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Transplantation and Cellular Therapy|April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Muscle & Nerve|December 19, 2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trialMichael D Weiss, Eric A Macklin, Courtney E McIlduff, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster seraWei Wang, Gitanjali L Bhushan, Stephanie Paz, et al.
Iscience|July 18, 2024
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept studyTewodros Mulugeta Dagnew, Chieh-En J Tseng, Chi-Hyeon Yoo, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Nature Medicine|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim resultsAndras Heczey, Xin Xu, Amy N Courtney, et al.
Pageof 118

Showing results (1131-1140 of 1,173) with videos related to

Sort By:
Pageof 118
The Science of the Total Environment|May 8, 2020
Comment on: "A novel approach to peatlands as archives of total cumulative spatial pollution loads from atmospheric deposition of airborne elements complementary to EMEP data: Priority pollutants (Pb, Cd, Hg)" by Ewa Miszczak, Sebastian Stefaniak, Adam Michczyński, Eiliv Steinnes and Irena TwardowskaF De Vleeschouwer, S Baron, J M Cloy, et al.
Journal of Virology|October 4, 2024
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Transplantation and Cellular Therapy|April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Muscle & Nerve|December 19, 2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trialMichael D Weiss, Eric A Macklin, Courtney E McIlduff, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster seraWei Wang, Gitanjali L Bhushan, Stephanie Paz, et al.
Iscience|July 18, 2024
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept studyTewodros Mulugeta Dagnew, Chieh-En J Tseng, Chi-Hyeon Yoo, et al.
Pain|June 25, 2013
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Richard C Dart, Nathaniel P Katz, et al.
Nature Medicine|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim resultsAndras Heczey, Xin Xu, Amy N Courtney, et al.
Pageof 118